Dedifferentiated liposarcoma lacks effective IGF-1→PPAR-γ adipogenic signaling due to epigenetic silencing of PPAR-γ2, with ...
Tentative approval for PNT2003 positions it as the first FDA-cleared radioequivalent of Lu 177 dotatate, with anticipated ...